Olympus Corporation
Notice Regarding Additional Investment in Corporate Venture Capital “Olympus Innovation Ventures Fund II”
Olympus Corporation has decided to make an additional investment in Olympus Innovation Ventures Fund II to strengthen collaboration with early-stage companies.
Key Figures
- Investment Amount: 200 million USD (approx. 31.3 billion JPY)
- Counterparty: Olympus Innovation Ventures, LLC
- Implementation Timing: December 2025
- Revenue Contribution: Minimal (fiscal year ending March 2026)
AI要約
Overview of Business Progress
Olympus Corporation has decided to make an additional capital contribution to Olympus Innovation Ventures Fund II (OIV Fund II), a corporate venture capital fund, as part of its new management strategy aimed at growth as a global medtech company. OIV Fund II invests in early-stage companies and fosters partnerships with entrepreneurial teams related to Olympus’ technologies. The initial investment was 50 million USD, and multiple subsequent capital increases are planned, targeting a total contribution of 200 million USD.
Future Developments and Impact on Management
OIV Fund II searches for and invests in companies with differentiated technologies, supporting robotics technology that pioneers the future of endoscopic medical care and growth strategies in China and emerging markets. The impact on performance for the fiscal year ending March 2026 is expected to be minimal, with additional investments to be made based on future opportunities. This initiative aims to create growth opportunities and strengthen the Company’s portfolio.
